PINX: RYLPF
- Last Close 18.99
- Sector Healthcare
- Industry Medical Devices
- Investment Style Mid Blend
- Day Range 18.99 – 19.25
- Year Range 11.44 – 22.46
- Market Cap 17.4899 Bil
- Volume / Avg 766.0 / 19,635.9
- Price / Sales 0.91
- Price / Book 1.23
- Forward Div Yield —
- Trailing Div Yield 4.48%
Morningstar‘s Stock Analysis RYLPF
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile RYLPF
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of RYLPF’s competitive advantage.
Koninklijke Philips NV
PINX: RYLPF
| General Electric Co
XNYS: GE
| Siemens AG
XETR: SIE
| Siemens Healthineers AG Registered Shares
XFRA: SHL
| |
Price
| 18.99 | 106.30 | 158.14 | 52.34 |
Currency
| USD | USD | EUR | EUR |
Change
| −$0.21 (1.08%) | +$0.23 (0.22%) | −$0.62 (0.39%) | −$0.40 (0.76%) |
Market Cap
| 17.49 Bil | 115.76 Bil | 125.33 Bil | 58.59 Bil |
Industry
| Medical Devices | Specialty Industrial Machinery | Specialty Industrial Machinery | Medical Devices |
Sector
|
Healthcare
|
Industrials
|
Industrials
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Koninklijke Philips NV Stock
No. RYLPF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
RYLPF’s market cap is 17.49 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
RYLPF’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
RYLPF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare RYLPF’s historical performance against its industry peers and the overall market.